To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Summary PDF
Document: Download guidance (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Summary PDF
Document: Download (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Supporting evidence
Document: Committee papers (PDF 6.49 MB) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Resource impact
Document: Resource impact template (Excel 2.24 MB) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Resource impact
Document: Resource impact summary report (Excel 2.24 MB) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Guidance published
Document: TA645 Committee papers (FDG) (PDF 6.73 MB) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Guidance published
Document: TA645 Final draft guidance (PDF 294 KB) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Guidance published
Document: TA645 Final scope (PDF 180 KB) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Guidance published
Document: TA645 Final stakeholder list (PDF 187 KB) (webpage)
Arms Length Body Publication (Published)
NICE

Jan. 08 2026

Source Page: Avelumab with axitinib for untreated advanced renal cell carcinoma
Publication Type: Declaration of interests
Document: Register of interests (PDF 141 KB) (webpage)